Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlighted its rapid advancement and major milestones achieved since the January 2024 leadership transition. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/304722_adia_med_x_banner.jpg On January 22, 2024, Larry Powalisz assumed the role of CEO and Director following a change of control, with Rebecca Miller appointed as CFO.

newsfilecorp.com - 2026-07-13 09:00:00

Name change to appear on Daily List today following expedited review; trading begins tomorrow Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline. The name change will be reflected on the FINRA Daily List today, with trading under the new name expected to begin tomorrow, Friday, July 10, 2026, on the OTC Markets.

newsfilecorp.com - 2026-07-09 08:00:00

Company Believes All Requirements Satisfied; Approval Expected in the Coming Weeks Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition Inc. to Adia Med Inc. After several months of review by the Financial Industry Regulatory Authority (FINRA), including three rounds of comments and the submission of detailed supporting documentation, the Company believes it has now met all outstanding requirements. FINRA approval is anticipated within the coming weeks.

newsfilecorp.com - 2026-07-07 10:19:00

CEO Larry Powalisz Spotlights Dr. Lyday, a Leading Stem Cell Champion, in New Podcast. Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today announced that CEO Larry Powalisz recently sat down for a podcast interview with Dr. Lyday, a physician recognized as a champion for stem cell-based treatments.

newsfilecorp.com - 2026-06-30 12:49:00

Dr. Brian Browning to train APRNs and RNs on Butterfly portable ultrasound for more precise, comfortable, and reliable IV therapies Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Butterfly portable ultrasound device.

newsfilecorp.com - 2026-06-16 10:55:00

Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/300817_screenshot_adia_med_inc_official_on_nevada.jpg The move is more than cosmetic — it's a clear signal of where Adia is headed. Shifting from "Nutrition" to "Med" puts the spotlight on the company's growing emphasis on advanced medical and wellness solutions.

newsfilecorp.com - 2026-06-10 09:15:00

Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its new wholly-owned subsidiary, ADIA Life LLC, headquartered in the state of Florida. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/300531_screenshot_adia_life_llc_registration.jpg ADIA Life LLC was strategically created to serve as the central hub for managing distribution of Adia Labs' cutting-edge products while also overseeing a growing network of authorized distributors nationwide.

newsfilecorp.com - 2026-06-08 12:51:00

Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE superstar Jeff Sciullo, known to fans worldwide as Elias (or Elijah), is in final editing and racing toward release! Wrestler's Tricep Tears Off Bone During Match!

newsfilecorp.com - 2026-06-02 09:30:00

Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced that an independent monthly-membership health care sharing ministry — where members pay monthly dues as an alternative to traditional health insurance — now accepts up to three stem cell treatments per client. This expanded coverage provides eligible members with greater access to advanced stem cell therapies for regenerative applications.

newsfilecorp.com - 2026-05-26 08:00:00

Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07572890#study-overview To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/298208_kidneystudy.jpg Each study is enrolling up to 100 participants.

newsfilecorp.com - 2026-05-20 11:57:50

Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd party reviewed financial results for the first quarter ended March 31, 2026, highlighting significant year-over-year revenue growth and continued expansion of its biologics and medical procedures segments. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001160420/000168316826003957/adia_i10q-033126.htm To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/297620_adia_image1.jpg Key Highlights for Q1 2026 (compared to Q1 2025): Total Revenue increased 146% to $176,275 from $71,764, reflecting strong demand and successful diversification of revenue streams.

newsfilecorp.com - 2026-05-15 07:59:00

Winter Park Autism Study Now Treating Patients; Kidney Study Recruitment to Begin This Week Winter Park, Florida--(Newsfile Corp. - May 11, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine through its subsidiary Adia Med of Winter Park, LLC, today announced that all four of its planned clinical studies have received Institutional Review Board (IRB) approval. This milestone enables the continued execution and launch of human trials evaluating the safety and potential efficacy of the Company's proprietary AdiaVita™ stem cell and exosome therapies.

newsfilecorp.com - 2026-05-11 10:04:00

Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for chronic diseases, today announced that its pivotal clinical study on kidney disease has received Institutional Review Board (IRB) approval and has been successfully submitted to ClinicalTrials.gov. Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD) To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/295970_ckdstudy.jpg This milestone marks an important step in Adia Nutrition's ongoing research into new approaches for studying kidney disease.

newsfilecorp.com - 2026-05-05 10:08:00

Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research pipeline. Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/294388_adiaimage.jpg The company has successfully received the second round of comments back from the Institutional Review Board (IRB) for its Lower Back Pain Study.

newsfilecorp.com - 2026-04-28 08:30:00

Winter Park, Florida--(Newsfile Corp. - April 15, 2026) -  Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products, today announced that it is in the process of changing its corporate name to Adia Med, Inc. The name change reflects the company's evolving business model, which has shifted significantly toward advanced medical treatments and biologics. Adia now operates through key divisions including Adia Med clinics (offering stem cell therapies, platelet-rich plasma (PRP), autologous hematopoietic stem cell transplantation (AHSCT), therapeutic plasma exchange, orthopedic care, pain management, and wound repair) and Adia Labs, which develops and sells biologic products such as AdiaVita and AdiaLink.

newsfilecorp.com - 2026-04-15 08:30:00